Top Medical Stocks For 2019

The map of the United States is already looking greener than ever, and now there are five more U.S. states that could legalize marijuana in 2017…

So far, a total of 29 states have legalized marijuana in some form, including the District of Columbia.

This bodes well for those invested in marijuana stocks. As more states legalize marijuana, new opportunities for cannabis companies are created, according to Money Morning Director of Technology & Venture Capital Research Michael Robinson.

“In November, voters in five states (read, five juicy untapped markets) voted to legalize medical and recreational marijuana,” Robinson said. “That boosted the cannabis niche’s growth prospects immensely. Remember, this is an investing arena that was already expected to grow by more than 31% a year until at least the early 2020s.”

Top Medical Stocks For 2019: Iteris, Inc.(ITI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Iteris (NASDAQ: ITI) and Napco Security Technologies (NASDAQ:NSSC) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

  • [By Ethan Ryder]

    Iteris Inc (NASDAQ:ITI) has received an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $9.50.

  • [By Stephan Byrd]

    Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Shane Hupp]

    B. Riley set a $9.00 price target on Iteris (NASDAQ:ITI) in a research report sent to investors on Wednesday morning. The brokerage currently has a buy rating on the technology company’s stock. B. Riley also issued estimates for Iteris’ Q4 2018 earnings at ($0.04) EPS, FY2018 earnings at ($0.08) EPS, Q1 2019 earnings at ($0.02) EPS, Q2 2019 earnings at ($0.05) EPS, Q3 2019 earnings at ($0.01) EPS, Q4 2019 earnings at ($0.04) EPS, FY2019 earnings at ($0.11) EPS, FY2020 earnings at $0.16 EPS and FY2021 earnings at $0.52 EPS.

Top Medical Stocks For 2019: Tidewater Inc.(TDW)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Tidewater Inc (NYSE:TDW)Q2 2018 Earnings Conference CallAug. 14, 2018, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Tidewater (NYSE:TDW) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday.

  • [By Ethan Ryder]

    Brookfield Infrastructure Partners (NYSE: TDW) and Tidewater (NYSE:TDW) are both utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

  • [By Shane Hupp]

    News headlines about Tidewater (NYSE:TDW) have been trending somewhat positive on Monday, Accern reports. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tidewater earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave headlines about the oil and gas company an impact score of 45.9223416083374 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Tidewater alerts:

    Golar LNG (GLNG) and Tidewater (TDW) Head to Head Survey (americanbankingnews.com) New Dedicated Senior Medical Center Brings Affordable Concierge-Style Health Care to Bradenton Seniors (prweb.com) Tidewater Inc. (TDW) Sees Significant Growth in Short Interest (americanbankingnews.com) Tidewater to Buy Offshore Supply Vessel Operator GulfMark (wsj.com) Tidewater to Buy GulfMark, Form Combined Entity Worth $1.25B (finance.yahoo.com)

    Shares of Tidewater traded down $0.10, reaching $31.49, during trading on Friday, MarketBeat.com reports. 158,400 shares of the company were exchanged, compared to its average volume of 183,937. Tidewater has a 12-month low of $20.37 and a 12-month high of $35.98. The company has a quick ratio of 3.71, a current ratio of 3.84 and a debt-to-equity ratio of 0.43.

  • [By Logan Wallace]

    Hornbeck Offshore Services (NYSE: TDW) and Tidewater (NYSE:TDW) are both small-cap oils/energy companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

Top Medical Stocks For 2019: Nicholas Financial Inc.(NICK)

Advisors’ Opinion:

  • [By Max Byerly]

    CPI Card Group (NASDAQ: PMTS) and Nicholas Financial (NASDAQ:NICK) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Stephan Byrd]

    Nicholas Financial (NASDAQ: NICK) and CPI Card Group (NASDAQ:PMTS) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

  • [By Ethan Ryder]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

  • [By Logan Wallace]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, profitability and risk.

Top Medical Stocks For 2019: Unique Fabricating, Inc.(UFAB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Unique Fabricating (NASDAQ:UFAB) has trended somewhat positive this week, Accern Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Unique Fabricating earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned media stories about the company an impact score of 47.3756147302874 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Ethan Ryder]

    Unique Fabricating (NYSEAMERICAN:UFAB)‘s stock had its “buy” rating reaffirmed by equities researchers at Roth Capital in a report released on Wednesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Unique Fabricating (UFAB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks For 2019: Innophos Holdings, Inc.(IPHS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    TheStreet upgraded shares of Innophos (NASDAQ:IPHS) from a c+ rating to a b rating in a research note published on Wednesday.

    Several other analysts also recently issued reports on the stock. Zacks Investment Research downgraded shares of Innophos from a hold rating to a sell rating in a report on Tuesday, February 27th. BidaskClub downgraded shares of Innophos from a sell rating to a strong sell rating in a report on Tuesday, February 27th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Innophos (IPHS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Leave a Reply

Your email address will not be published. Required fields are marked *